Kanagawa, Japan

Yumiko Kawai

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Inventor Yumiko Kawai: Pioneering Cancer Therapy Innovations**

Introduction

Yumiko Kawai, an inventive force based in Kanagawa, Japan, has made significant contributions to cancer treatment through her innovative research and patentable inventions. With a total of four patents to her name, she continues to push the boundaries of medical science.

Latest Patents

One of Yumiko Kawai's latest inventions is a therapeutic drug designed to induce cell injury for use in cancer therapy. This invention provides anticancer agents that include a bispecific antibody featuring a domain that binds to glypican 3, combined with a domain that connects to a T cell receptor complex. These antibodies are developed to enhance the affinity for both antigens, resulting in a powerful therapeutic option. The pharmaceutical compositions containing this bispecific antibody are intended to be used alongside other anticancer agents, demonstrating their unique ability to tackle various forms of cancer.

Another significant patent focuses on a cytotoxicity-inducing therapeutic agent. By innovating the antigen-binding domain, Kawai has discovered novel polypeptide complexes that maintain the strong anti-tumor activity associated with BiTE (Bispecific T-cell Engager) technology. These new complexes offer excellent safety properties, a long half-life in the bloodstream, and the capability to target different types of cells effectively.

Career Highlights

Yumiko Kawai is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent player in the pharmaceutical industry. Her work at Chugai highlights her dedication to developing groundbreaking cancer therapies that can significantly impact patient care and outcomes.

Collaborations

Throughout her career, Kawai has collaborated with talented individuals such as Takahiro Ishiguro and Junichi Nezu. These partnerships have likely contributed to her innovative research, combining diverse expertise to create cutting-edge therapies in the fight against cancer.

Conclusion

Yumiko Kawai stands out as a remarkable inventor in the realm of cancer treatment, with her groundbreaking patents paving the way for novel therapeutic approaches. Her work not only highlights her ingenuity as an inventor but also underscores the importance of collaboration in advancing medical science. With these innovations, Kawai is poised to make lasting contributions to oncology and improve the lives of many patients facing cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…